For health conditions with no cure, effective treatments are the next best option. However, in order to make medical ...

The key processes of skin aging are now being understood in sufficient detail that targeted prescription therapies for ...

ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeksBLA resubmission on track for calendar Q1 2025Entered into agreements for warrant inducement transaction expected to result in up to $20 ...

The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, ...

Linsitinib, an oral small molecule under development for the treatment of thyroid eye disease, demonstrated proptosis reduction and safety in the phase 2b/3 LIDS trial, according to a press release ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new interim data ...

Mojisola Adeyeye, the director-general of the National Agency for Food and Drug Administration and Control (NAFDAC), says the ...

She said although herbal medicines are effective, the agency cannot approve their usage without clinical trials ...

Prof. Mojisola Adeyeye, the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), is ...